Thus, reducing LXRα pS196 in hematopoietic cells attenuates atherosclerosis and obesity by reprogramming the transcriptional activity of LXRα in macrophages and T cells to promote an anti-inflammatory phenotype. The gene discussed is NR1H3; the disease is obesity due to melanocortin 4 receptor deficiency.